Derived from “Ayurvedic wisdom”: Fortiquin botanical formula targets male sexual performance
The vegan nutraceutical formula is marketed as an enhancement to reproductive, vascular and nervous systems
16 Apr 2019 --- An all-natural, vegan nutraceutical formula targeting male sexual health has been developed by the DolCas-Tenshi Bioceuticals joint venture, marketed under the brand Fortiquin. The five-ingredient, patent-pending blend of herbal extracts and nutrients is said to promote sexual stamina and overall well-being in healthy men who experience problems with sexual performance. The company will launch the new product at Vitafoods Europe in Geneva on May 7-9, 2019.
Derived from the “wisdom of the Ayurvedic medical tradition,” Fortiquin is composed of four botanicals: mucuna, cynara, trigonella and ashwagandha, combined with the amino acid L-arginine. The proprietary blend of natural ingredients is said to work in synergy to nourish and balance multiple systems for the overall enhancement of men’s health and more specifically, sexual stamina. Comprehensive clinical studies are still ongoing, the company notes.
“Fortiquin is an all-natural powerhouse blend of botanicals,” explains Shavon Jackson-Michel, ND, Director of Medical and Scientific Affairs for DolCas-Tenshi. “The individual herbs coexist as clean-label extracts, rather than powders, delivering not only an enriched profile of the phytochemicals most associated with their functionality and organ affinity, but also ensuring consistent quality from batch to batch.”
The symbiotic blend of extracts, in proprietary ratios, are standardized to their bioflavonoid and saponin contents. These two classes of phytochemicals are commonly touted for their therapeutic activity, including their effects on the reproductive, vascular and nervous systems.
“DolCas-Tenshi is attentive to the drive for increased standardization of quality for all aspects of developing natural sexual health products,” adds Vivek A. Parachur, Co-Founder and CEO of Olene Life Sciences, developer and manufacturer of Fortiquin. “This encompasses sourcing, storage and clinical assessment of bioactivity and efficacy. Lack of such attention can leave the consumer with little confidence in product effectiveness.”
Several factors are driving the expansion of the market for sexual performance aids, the company says. Evolvement of societal perceptions and norms regarding sexual intimacy is eliciting increased customer acceptance of sexual enhancement supplements. Additionally, the anonymity and convenience of internet shopping appears to encourage increased e-commerce activity within this sector.
The publication of research on Fortiquin’s clinical effects on sexual function in men is expected in the late spring of this year. The uniqueness of the product’s composition potentially avails it to other clinical functions, such as sports performance and menopausal support, according to the company. Dolcas-Tenshi plans to further investigate Fortiquin’s applicability for these additional health areas.
By Benjamin Ferrer
